Dreem SAS

Acquired

San Francisco, CaliforniaFounded 2014101–250 employeesdreem.comLinkedIn

Sleep disorders

Dreem Health is a fully virtual sleep clinic providing at-home diagnosis and treatment for sleep apnea and other sleep disorders. Its coordinated care model connects patients with sleep specialists, diagnostic services, and treatment support nationwide, with insurance coverage available.

Visit dreem.com ↗

Founded: 2014
Employees: 101–250

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

Dreem’s clearest strategic milestone is its transition from a consumer neurotechnology company into a broader sleep-care platform. The company raised $35 million in its largest disclosed round on Jun 26, 2018, following $11 million rounds in 2017 and 2016, for total disclosed funding of $57 million. Its original product proposition centered on the Dreem wearable, which monitored brainwaves and used sound stimulation to extend deep sleep. The Dreem 2 headband launched in the United States on Sep 10, 2019, marking a move toward a more mature consumer sleep product. The company’s ownership history is less clear: a structured transaction identifies Sunrise as the acquirer on Feb 22, 2024, while a separate 2023 announcement describes an acquisition by Beacon Biosignals. The current website positions Dreem Health as a Sunrise Group-managed virtual sleep clinic offering at-home diagnosis and treatment.

Market position

Dreem occupies the intersection of neurotechnology, wearable hardware, sleep diagnostics, and virtual care. Its earlier differentiation was unusually technical for a consumer sleep product: the Dreem wearable combined brainwave monitoring, sleep analysis, and acoustic stimulation intended to improve deep sleep. Its current positioning is broader, emphasizing an end-to-end virtual pathway for sleep apnea and other sleep disorders, including at-home testing, specialist consultations, treatment support, and insurance navigation. That model places Dreem closer to digitally enabled sleep-medicine providers and remote-monitoring businesses than to standalone consumer wearables. Relative to generic sleep trackers, Dreem’s stated advantages are clinical integration, FDA-cleared home diagnostics, dedicated sleep professionals, and coordinated treatment workflows. Relative to traditional sleep clinics, its virtual delivery and home-based testing may reduce referral friction and specialist wait times. However, the record does not provide current patient volume, reimbursement performance, clinical outcomes, or market share, limiting confidence in its present competitive strength.

Growth & opportunities

Dreem’s trajectory shows a progression from hardware-led neurotechnology to clinically oriented sleep care. Founded in July 2014, the company raised $11 million in Series A funding in March 2016, another $11 million in June 2017, and $35 million in June 2018. The $57 million total supported development and commercialization of its brain-sensing sleep wearable, culminating in the U.S. launch of Dreem 2 on Sep 10, 2019. The later business model appears to have expanded beyond direct-to-consumer hardware. Dreem Health now describes a virtual clinic combining at-home sleep studies, remote visits, specialist care, treatment coordination, and insurance support. This represents a meaningful inflection point from selling a device to managing a care pathway. Ownership changes may have accelerated that shift, although the record contains conflicting references to Beacon Biosignals in 2023 and Sunrise in 2024. Growth therefore appears strategically plausible but quantitatively difficult to validate.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Dreem SAS distinct

reccy insights

What makes Dreem SAS distinct

01Provides end-to-end sleep care virtually, from diagnosis through treatment.
02Offers at-home sleep studies and virtual visits designed for faster, simpler access.
03Care is delivered by dedicated sleep specialists, including physicians, nurse practitioners, respiratory therapists, sleep technologists, and care coordinators.
04Nationwide, insurance-supported care helps patients avoid fragmented referrals and long specialist wait times.
05Managed by the Sunrise Group with a focus on sleep science, peer-reviewed research, and FDA-cleared diagnostic technology.

Technology & products2

Technology & products

Dreem
A wearable device that monitors brainwaves, analyzes sleep, and uses sound stimulation to enhance deep sleep.
Dreem Health Virtual Sleep Clinic
A virtual care platform providing at-home diagnosis and treatment support for sleep apnea and other sleep disorders.

FDA-cleared at-home diagnostic technology for sleep disorders
At-home sleep study platform
Smart automation for administrative workflows
Integrated tools across clinical and operational roles
Real-time operational insights
Brainwave monitoring and sound-based sleep stimulation through the Dreem wearable

About Dreem SAS

Products: Dreem, Dreem Health Virtual Sleep Clinic
Leadership: Hugo Mercier, FounderQuentin Soulet de Brugiere, Co-Founder & CEO
Focus areas: Digital health, sleep medicine, telehealth, healthcare, diagnostics, medical devices, sleep apnea, at home care
Headquarters: San Francisco, California
Founded: 2014
Employees: 101–250
Status: Acquired